Aadi Bioscience Announces Exploratory Biomarker Data from Patients in Its AMPECT Trial and Expanded Access Program to be Presented at 2022 ASCO Annual Meeting
Go back to Aadi Bioscience Announces Exploratory Biomarker Data from Patients in Its AMPECT Trial and Expanded Access Program to be Presented at 2022 ASCO Annual Meeting| American Asset Development, Inc. (NASDAQ: AADI) | Delayed: 1.78 -0.06 (3.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.84 | 52 Week High | $0.00 | |||
| Open | $1.85 | 52 Week Low | $0.00 | |||
| Day High | $1.85 | P/E | N/A | |||
| Day Low | $1.76 | EPS | $0.00 | |||
| Volume | 110,341 | |||||
